Micron Biomedical Extends Series A to $17 Million to Bring Needle-Free Drugs and Vaccines to Market
/PRNewswire/ -- Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that are simplifying and advancing...
Source: prnewswire.com